Atrial Cardiomyocytes

  • Atrial Cardiomyocytes

Human iPSC-derived Atrial Cardiomyocytes

Engineered to express atrial-specific electrophysiological and molecular signatures. They beat at spontaneous rates and have action potential morphologies characteristic of atrial cardiomyocytes—useful for atrial arrhythmia modeling and for testing drugs targeting atrial-selective pathways.

Benefits

  • Atrial gene marker expression (e.g. KCNA5, NPPA, GIRK (IKAch))
  • Electrophysiological profiles suited to atrial physiology studies
  • Strong for comparative studies vs ventricular types; arrhythmia / AFib models

Product Specifications

Figure 2. Atrial hiPSC-CM electrophysiological validation. Atrial hiPSC-CM APD90 << Ventricular hiPSC-CM APD90. Greenstone atrial hiPSC-CMs respond to Dofetilide (100nM) as expected with significant APD prolongation.

  • Identity: high purity atrial marker expression; minimal ventricular contamination
  • Sizes, QC, format, shipping as per ventricular line
  • Functionality: response to atrial-relevant ion channel modulators; beat rate and action potentials matching atrial reference data
  • Response to adrenergic stimulation (e.g. isoproterenol) as well as to ion channel blockers (e.g. L-type Ca²⁺ channel blockers, hERG blockers, Na channel blockers)
  • Atrial CM APD<<Ventricular CM APD

Explore Atrial Cardiomyocytes

Discover our high-purity, iPSC-derived ventricular cardiomyocytes designed for cardiac safety, electrophysiology, and drug discovery research. Check out the product details to see how these cells can accelerate your studies.

Our Products